Fundraising Fox

Dmitrij Hristodorov

InvestorFounder

General Partner at Forbion · Board director at Memento Medicines

Munich, Germany

Writes $100K – $5M checks · typically $1.5M

FoundedMemento Medicines

About

Dmitrij Hristodorov is a General Partner at Forbion, where his portfolio spans multiple stages, treatment modalities, and disease areas. He previously held R&D Ophthalmology and Business Development roles at Bayer Pharma. He earned a PhD from the University of Aachen (RWTH) in 2013 for immunology work conducted at the Fraunhofer Institute.

Invests in

Biotech

Board director at Memento Medicines

Intro paths

→

In turn, Dmitrij can intro founders to Memento Medicines's investors below.

Memento Medicines's investors · 5

Avego BioScience CapitalAlpharetta · since 2026ForbionNaarden · since 2026RA CapitalBoston · since 2026Samsara BioCapitalPalo Alto · since 2026Sanofi VenturesCambridge · $5M checks · since 2026

Co-founders at Memento Medicines

WD
William Daley BonificioExecutive Officer, Promoter
SB
Stephen Basil ThomasExecutive Officer, Promoter
NM
Naveen Manu DaryaniExecutive Officer, Director, Promoter

Experience

  1. ForbionGeneral Partnercurrent2024 — presentMünchen, Bayern, Deutschland
  2. ForbionPartner2021 — 2024München, Bayern, Deutschland
  3. ForbionPrincipal2021München, Bayern, Deutschland
  4. ForbionSenior Associate2020München, Bayern, Deutschland
  5. Memento MedicinesBoard Membercurrent2026 — present
  6. Mosanna TherapeuticsBoard Membercurrent2025 — present
  7. Beacon TherapeuticsBoard Membercurrent2024 — present
  8. Progentos TherapeuticsBoard Membercurrent2024 — present
  9. KynexisBoard Membercurrent2022 — present
  10. AAVantgarde BioBoard Membercurrent2023 — presentItaly
  11. Seamless TherapeuticsBoard Membercurrent2022 — present
  12. Complement TherapeuticsBoard Membercurrent2022 — present
  13. RyCarma TherapeuticsBoard Membercurrent2021 — present
  14. Rampart BioscienceBoard Member2023 — 2025
  15. OxularBoard Member2021 — 2024Oxford
  16. VectorYBoard Observer2020 — 2023Amsterdam
  17. Gyroscope TherapeuticsBoard Observer2021 — 2022Stevenage
  18. Bayer PharmaceuticalsSenior Director, Global Business Development & Licensing2018 — 2020Berlin Area, Germany
  19. Bayer PharmaceuticalsDirector, Early Licensing, Global Business Development2016 — 2018Berlin Metropolitan Area
  20. Bayer PharmaceuticalsProject Leader/Alliance Manager2015Baltimore, Maryland Area

Education

  1. RWTH Aachen UniversityDr. rer. nat. (PhD), Biotechnology; Immunology2011 — 2013
  2. RWTH Aachen UniversityMaster of Science (MS), Biotechnology2009 — 2011
  3. RWTH Aachen UniversityBachelor of Science (BS), Biotechnology2006 — 2009
  4. Gymnasium Zitadelle JülichAbitur, Abitur1998 — 2005

Skills & more

Life Sciences27Business Development12Ophthalmology12Immunology19Biotechnology10Licensing2Cancer Research13Inflammation8Pharmaceutical Industry2Drug Development3

Languages English · German · Russian

From Dmitrij's professional profile.

Deals · 1

Memento MedicinesBoard seat

via Forbion · filed Jun 2026 · $93M raise

press ↗

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Forbion

Alexander Hoffmann
General Partner at Forbion
Alice Vickers
Advisor at Forbion
Antoine Boulanger Piette
Principal at Forbion
Audrey Cacaly
Principal at Forbion
Carlo Incerti
Operating Partner at Forbion
Dirk Kersten
Managing Partner at Forbion
Geert-Jan Mulder
Managing Partner at Forbion
Holger Reithinger
General Partner at Forbion

Network6

Alice Vickers
Advisor at Forbion
Antoine Boulanger Piette
Principal at Forbion
Audrey Cacaly
Principal at Forbion
Dan Janney
Managing Director at Alta Partners
Dirk Kersten
Managing Partner at Forbion
Holger Reithinger
General Partner at Forbion

Investors connected to Dmitrij in public investor directories — a warm-intro map.

Frequently asked questions

Where does Dmitrij Hristodorov work?
Dmitrij Hristodorov is General Partner at Forbion and Founder at Memento Medicines.
What does Dmitrij Hristodorov invest in?
Dmitrij Hristodorov invests in Biotech.
What check size does Dmitrij Hristodorov write?
Dmitrij Hristodorov typically writes checks of $100K – $5M.
What companies did Dmitrij Hristodorov found?
Dmitrij Hristodorov founded Memento Medicines.

Same school

Also attended RWTH Aachen University49

Dr. Nils EiteneyerPartner at CapnamicJason GrüningerInvestment Manager at CapnamicAbdulla ElyasAdvisor at RAED VenturesFrederike WolffInvestment Team at RedstoneAlexander KüppersInvestment Director at Statkraft VenturesEmil JerslingSenior Growth Manager at Orbit Startups

+ 43 more

Shared employers

Also worked at Seamless Therapeutics2

Arturo UrriosPartner at Ysios CapitalHolger ReithingerGeneral Partner at Forbion

Also worked at Oxular2

Christina TakkeManaging Partner at V-Bio VenturesInga DeakinPrincipal at Molten Ventures

Also worked at VectorY5

Alexander VosVenture Partner at BioGeneration VenturesMarco BoorsmaGeneral Partner at ForbionWouter JoustraGeneral Partner at ForbionRianne EllenbroekPrincipal at BioGeneration VenturesArno de WildeInvestor at EQT Life Sciences

Also worked at Bayer Pharmaceuticals69

Vincent RoseInvestment Manager at Burda Principal InvestmentsJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesMelike Abacioglu GunesVP of Marketing at Asymmetric Capital PartnersChris PatersonVenture Partner at Tall Grass VenturesDavid SullivanVenture Partner at Tall Grass Ventures

+ 63 more